We serve Chemical Name:1-phenylpiperazine-2,3-dione CAS:59702-39-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-phenylpiperazine-2,3-dione
CAS.NO:59702-39-5
Synonyms:1-phenyl-piperazine-2,3-dione
Molecular Formula:C10H10N2O2
Molecular Weight:190.19900
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.261g/cm3
Index of Refraction:1.578
PSA:49.41000
Exact Mass:190.07400
LogP:0.54320
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-phenyl-piperazine-2,3-dione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-phenyl-piperazine-2,3-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-phenyl-piperazine-2,3-dione Use and application,1-phenyl-piperazine-2,3-dione technical grade,usp/ep/jp grade.
Related News: Analogous to master cell lines used to manufacture biopharmaceutical drug products such as monoclonal antibodies, clonal master iPSC lines are a renewable source for manufacturing cell therapy products which are well-defined and uniform in composition, can be mass produced at significant scale in a cost-effective manner, and can be delivered off-the-shelf for patient treatment. 1-phenylpiperazine-2,3-dione manufacturer But Vietnam then partly eased its ban, allowing flights from Hong Kong and Macau to continue, aviation authorities said. 1-phenylpiperazine-2,3-dione supplier In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials. 1-phenylpiperazine-2,3-dione vendor Analogous to master cell lines used to manufacture biopharmaceutical drug products such as monoclonal antibodies, clonal master iPSC lines are a renewable source for manufacturing cell therapy products which are well-defined and uniform in composition, can be mass produced at significant scale in a cost-effective manner, and can be delivered off-the-shelf for patient treatment. 1-phenylpiperazine-2,3-dione factory In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.
